Smoking cessation drug shows potential to treat Parkinson s disease in females
Texas A&M University College of Medicine ressearchers have recently discovered that cytisine a smoking cessation drug commonly used in Europe reduces the loss of dopamine neurons in females. These findings provide potential evidence for the use of the drug to treat Parkinson s disease or stop its progression in women.
Sara Zarate and Gauri Pandey, graduate students from the lab of Rahul Srinivasan, assistant professor in the Department of Neuroscience & Experimental Therapeutics, are co-first authors of the research. Their findings are published in the
Journal of Neurochemistry.
Texas A&M University College of Medicine researchers have recently discovered that cytisine a smoking cessation drug commonly used in Europe reduces the loss of dopamine neurons in females. These findings provide potential evidence for the us
Smoking Cessation Drug Reduces Loss of Dopamine Neurons in Female Mice technologynetworks.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from technologynetworks.com Daily Mail and Mail on Sunday newspapers.